• Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models 

      Buociková, Verona; Longhin, Eleonora Marta; Pilalis, Eleftherios; Mastrokalou, Chara; Miklíková, Svetlana; Cihova, Marina; Poturnayova, Alexandra; Mackova, Katarina; Bábelová, Andrea; Trnkova, Lenka; El Yamani, Naouale; Zheng, Congying; Rios-Mondragon, Ivan; Labudova, Martina; Csaderova, Lucia; Kuracinova, Kristina Mikus; Makovicky, Peter; Kučerová, Lucia; Matuskova, Miroslava; Cimpan, Mihaela-Roxana; Dusinska, Maria; Babal, Pavel; Chatziioannou, Aristotelis; Gábelová, Alena; Rundén-Pran, Elise; Smolkova, Bozena (Journal article; Peer reviewed, 2022)
      Acquired drug resistance and metastasis in breast cancer (BC) are coupled with epigenetic deregulation of gene expression. Epigenetic drugs, aiming to reverse these aberrant transcriptional patterns and sensitize cancer ...
    • Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpression 

      Buociková, Verona; Tyciakova, Sylvia; Pilalis, Eleftherios; Mastrokalou, Chara; Urbanova, Maria; Matuskova, Miroslava; Demkova, Lucia; Medova, Veronika; Longhin, Eleonora Marta; Rundén-Pran, Elise; Dusinska, Maria; Rios Mondragon, Ivan; Cimpan, Mihaela-Roxana; Gábelová, Alena; Soltysova, Andrea; Smolkova, Bozena; Chatziioannou, Aristotelis (Journal article; Peer reviewed, 2022)
      Decitabine (DAC), a DNA methyltransferase (DNMT) inhibitor, is tested in combination with conventional anticancer drugs as a treatment option for various solid tumors. Although epigenome modulation provides a promising ...
    • Risk Governance of Emerging Technologies Demonstrated in Terms of its Applicability to Nanomaterials 

      Isigonis, Panagiotis; Afantitis, Antreas; Antunes, Dalila; Bartonova, Alena; Beitollahi, Ali; Bohmer, Nils; Bouman, Evert; Chaudhry, Qasim; Cimpan, Mihaela Roxana; Cimpan, Emil; Doak, Shareen; Dupin, Damien; Fedrigo, Doreen; Fessard, Valérie; Gromelski, Maciej; Gutleb, Arno C.; Halappanavar, Sabina; Hoet, Peter; Jeliazkova, Nina; Jomini, Stéphane; Lindner, Sabine; Linkov, Igor; Longhin, Eleonora Marta; Lynch, Iseult; Malsch, Ineke; Marcomini, Antonio; Mariussen, Espen; Fuente, Jesus M. de la; Melagraki, Georgia; Murphy, Finbarr; Neaves, Michael; Packroff, Rolf; Pfuhler, Stefan; Puzyn, Tomasz; Rahman, Qamar; Pran, Elise Rundén; Semenzin, Elena; Serchi, Tommaso; Steinbach, Christoph; Trump, Benjamin; Vrček, Ivana Vinković; Warheit, David; Wiesner, Mark R.; Willighagen, Egon; Dusinska, Maria (Journal article; Peer reviewed, 2020)
      Nanotechnologies have reached maturity and market penetration that require nano‐specific changes in legislation and harmonization among legislation domains, such as the amendments to REACH for nanomaterials (NMs) which ...